Bis(aminopropyl)laurylamine (also known as N,N-bis(3-aminopropyl)dodecan-1-amine) is a triamine that is used as a curing agent for epoxy resins and as an intermediate in the synthesis of other chemicals. It is a colorless to pale yellow liquid with a faint amine odor. It is soluble in water, ethanol, and other polar solvents. Bis(aminopropyl)laurylamine is synthesized by reacting laurylamine with acrylonitrile to form the corresponding nitrile, which is then reduced to the amine. The reaction is typically carried out in the presence of a catalyst, such as nickel or cobalt. Bis(aminopropyl)laurylamine has a number of industrial applications, including as a curing agent for epoxy resins, as an intermediate in the synthesis of other chemicals, and as a component of adhesives, sealants, and coatings. It is also used as a surfactant, emulsifier, and corrosion inhibitor. Bis(aminopropyl)laurylamine is a relatively safe compound, but it can be irritating to the skin and eyes. It should be handled with care and appropriate safety precautions should be taken.'
bis(aminopropyl)laurylamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 75407 |
| SCHEMBL ID | 24179 |
| MeSH ID | M0283124 |
| Synonym |
|---|
| pcj6308jue , |
| 1,3-propanediamine, n1-(3-aminopropyl)-n1-dodecyl- |
| ec 219-145-8 |
| unii-pcj6308jue |
| n-(3-aminopropyl)-n-dodecyl-1,3-propanediamine |
| n'-(3-aminopropyl)-n'-dodecyl-propane-1,3-diamine |
| lonzabec-12 |
| laurylamine dipropylenediamine |
| 1,3-propanediamine, n-(3-aminopropyl)-n-dodecyl |
| bis(aminopropyl)laurylamine |
| einecs 219-145-8 |
| n-(3-aminopropyl)-n-dodecylpropane-1,3-diamine |
| 1,3-propanediamine, n-(3-aminopropyl)-n-dodecyl- |
| n'-(3-aminopropyl)-n'-dodecylpropane-1,3-diamine |
| 2372-82-9 |
| FT-0629417 |
| n,n-bis-(3-aminopropyl)-dodecylamine |
| 1,3-propanediamine,n1-(3-aminopropyl)-n1-dodecyl- |
| AKOS015894470 |
| laurylamine dipropylenediamine [who-dd] |
| aminopropyl)-n-dodecyl-1,3-propanediamine, n-(3- |
| laurylamine dipropylenediamine [inci] |
| lonzabac-12.100 |
| n1-(3-aminopropyl)-n1-dodecylpropane-1,3-diamine |
| F1905-6424 |
| SCHEMBL24179 |
| n,n-bis(3-aminopropyl)dodecylamine |
| bis-(3-aminopropyl)-laurylamine |
| NYNKJVPRTLBJNQ-UHFFFAOYSA-N |
| W-109775 |
| bis(3-aminopropyl)dodecylamine |
| DTXSID3041243 |
| BCP23852 |
| mfcd04112927 |
| FS-6129 |
| Q27286479 |
| bis(3-aminopropyl)(dodecyl)amine |
| EN300-265848 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.76) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 3 (33.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||